AVNS VS BLTE Stock Comparison

PerformanceSentimentTechnicalsEarningsProfitVolatility
PerformanceSentimentTechnicalsEarningsProfitVolatility

Performance

AVNS
10/100

AVNS returned -19.03% in the last 12 months. Based on SPY's performance of 13.09%, its performance is below average giving it a score of 10 of 100.

BLTE
100/100

BLTE returned 52.13% in the last 12 months. Based on SPY's performance of 13.09%, its performance is above average giving it a score of 100 of 100.

Sentiment

AVNS
86/100

AVNS had a bullish sentiment score of 85.83% across Twitter and StockTwits over the last 12 months. It had an average of 1.00 posts, 0.00 comments, and 0.00 likes per day.

BLTE

"Sentiment" not found for BLTE

Technicals

AVNS
61/100

AVNS receives a 60 of 100 based on 14 indicators. 8 are bullish, 5 are bearish.

BLTE
64/100

BLTE receives a 64 of 100 based on 14 indicators. 8 are bullish, 4 are bearish.

Earnings

AVNS
10/100

AVNS has missed earnings 6 times in the last 20 quarters.

BLTE
10/100

BLTE has missed earnings 4 times in the last 20 quarters.

Profit

AVNS
46/100

Out of the last 20 quarters, AVNS has had 8 profitable quarters and has increased their profits year over year on 7 of them.

BLTE
10/100

Out of the last 13 quarters, BLTE has had 1 profitable quarters and has increased their profits year over year on 1 of them.

Volatility

AVNS
46/100

AVNS has had a lower than average amount of volatility over the last 12 months giving it a score of 45 of 100.

BLTE
61/100

BLTE has had a higher than average amount of volatility over the last 12 months giving it a score of 60 of 100.

All score calculations are broken down here to help you make more informed investing decisions

Avanos Medical, Inc. Summary

New York Stock Exchange / AVNS
Healthcare
Medical - Devices
Avanos Medical, Inc., a medical technology company, focuses on delivering medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions; and respiratory health products, such as closed airway suction systems and other airway management devices under the Ballard, Microcuff, and Endoclear brands. The company also provides a portfolio of non-opioid pain solutions, including acute pain products, such as On-Q and ambIT surgical pain pumps, Game Ready cold, and compression therapy systems; and interventional pain solutions, which offers minimally invasive pain-relieving therapies, such as Coolief pain relief therapy. It markets its products directly to hospitals and other healthcare providers, healthcare facilities, and other end-user customers, as well as through third-party wholesale distributors. The company was formerly known as Halyard Health, Inc. and changed its name to Avanos Medical, Inc. in June 2018. Avanos Medical, Inc. was incorporated in 2014 and is headquartered in Alpharetta, Georgia.

Belite Bio, Inc American Depositary Shares Summary

Nasdaq / BLTE
Healthcare
Biotechnology
Belite Bio, Inc, a clinical-stage biopharmaceutical drug development company, engages in the research and development of novel therapeutics targeting atrophic age-related macular degeneration and autosomal recessive stargardt diseases. Its lead product candidate is LBS-008, an oral once-a-day treatment that can reduce and maintain the delivery of vitamin A to the eye to reduce the accumulation of toxic vitamin A by-products in ocular tissue that is in phase 3 clinical trial. The company is also developing LBS-009, an anti-retinol binding protein 4 oral therapy targeting liver disease, including non-alcoholic fatty liver disease, nonalcoholic steatohepatitis, and type 2 diabetes, which is in the preclinical development phase. Belite Bio, Inc was founded in 2016 and is based in San Diego, California. Belite Bio, Inc operates as a subsidiary of Lin Bioscience International Ltd.